Loading Events

All Events

Healthcare Investments and Exits: Reshaping Healthcare After COVID-19

July 21 @ 1:00 pm - 2:00 pm

  • This event has passed.

The pandemic created enormous disruption across the global economy. But few industries felt it more than healthcare — and life science innovators everywhere have responded to the challenge.

On July 21, join lead report author Jonathan Norris, Managing Director, Business Development; Chris Moniz, Head of Northwest & Northeast Healthtech and Medical Devices; and special guest Julie Grant, General Partner, at Canaan Partners, as they discuss SVB’s midyear Healthcare Investments and Exits Report.  Register for the webinar to get the latest in-depth metrics.

Preliminary highlights as of June 15th include:

  • Venture fundraising dedicated to healthcare continued its rise from $16.8B at year-end 2020 to $21.8B in just the first half of 2021
  • Led by platform investments, crossover investments in biopharma continue to surge, generating positive momentum and an IPO pipeline for the public markets
  • Healthtech investments are at an all-time high!  At mid-year healthtech investments totaled $14.6B, surpassing last year’s full-year total of $11.4B (US and Europe)
  • IPO activity is up, but post-IPO performance in healthtech and biopharma are seeing a downward shift compared with the past two years


July 21
1:00 pm - 2:00 pm
Event Website